GlassScriptPhysician profile
Susan B Fleet
NPI 1053318030
$15,052.61
in general payments reported to CMS, 2019-2025
37 companies · $2,376 in 2025
The $2,376 reported for 2025 was more than what 83% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,827 · 2020: $1,534 · 2021: $2,309 · 2022: $2,630 · 2023: $2,546 · 2024: $1,831 · 2025: $2,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,641 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,640.95 |
| Education | $112.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,772.30 | 2019-2025 | |
| Janssen Biotech, INC. | $2,351.02 | 2019-2025 | Stelara, Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,205.16 | 2019-2025 | Trulance, Xifaxan, Relistor |
| Takeda Pharmaceuticals U.S.A., INC. | $1,522.58 | 2019-2025 | Entyvio, Gattex, Eohilia |
| Ironwood Pharmaceuticals, INC | $694.22 | 2019-2024 | Linzess |
| Pfizer INC. | $597.59 | 2019-2025 | |
| Celgene Corporation | $522.88 | 2021-2024 | Zeposia |
| Daiichi Sankyo INC. | $487.98 | 2019-2022 | |
| Intercept Pharmaceuticals, INC. | $434.75 | 2019-2024 | Ocaliva |
| Regeneron Healthcare Solutions, INC. | $311.84 | 2022-2025 | Dupixent |
| Ardelyx, INC. | $297.74 | 2022-2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $273.36 | 2024-2025 | Voquezna |
| Madrigal Pharmaceuticals | $261.45 | 2024-2025 | Rezdiffra |
| Lilly USA, LLC | $240.91 | 2023-2025 | Omvoh |
| Genzyme Corporation | $233.65 | 2022-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $220.39 | 2019-2024 | Dificid |
| Nestle Healthcare Nutrition INC. | $213.91 | 2020-2022 | |
| Gilead Sciences, INC. | $152.85 | 2021-2025 | |
| Allergan, INC. | $148.88 | 2019 | |
| Shionogi INC | $144.32 | 2019 | |
| Ferring Pharmaceuticals INC. | $123.10 | 2019-2023 | Cimzia, Rebyota |
| Braintree Laboratories, INC. | $114.96 | 2021-2025 | Suflave, Sutab |
| Axonics, INC. | $112.90 | 2020 | |
| Aimmune Therapeutics, INC. | $98.93 | 2024-2025 | Zenpep |
| Conmed Corporation | $81.03 | 2025 | Conmed Biliary, Conmed Generators |
| Medtronic, INC. | $73.06 | 2024 | Interstim |
| Amgen INC. | $71.98 | 2021-2023 | Avsola |
| Redhill Biopharma INC. | $65.91 | 2020-2022 | |
| Qol Medical, LLC | $45.22 | 2025 | Sucraid |
| Organon LLC | $42.28 | 2023-2025 | Hadlima, Renflexis |
| Exact Sciences Corporation | $33.35 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boston Scientific Corporation | $22.02 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $17.94 | 2025 | Iqirvo |
| Endo Pharmaceuticals INC. | $15.86 | 2021 | |
| Evoke Pharma, INC. | $15.85 | 2022 | |
| Shield Therapeutics INC | $15.56 | 2024 | |
| Fujifilm Healthcare Americas Corporation | $14.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Fleet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.